{"entity":{"id":"nct07160686","kind":"trial","name":"Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment","aka":["THROMBO-STOP"],"tldr":"A phase 3 trial in lung cancer, run by University of Birmingham, not yet recruiting.","summary":"Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment is a phase 3, randomised interventional study registered as NCT07160686 by University of Birmingham, with a registry enrolment figure of 1456 participants, started 2026-03-02 and due to reach its primary completion in 2029-09-30. Interventions recorded: Apixaban; Placebo. Conditions listed: Thromboprophylaxis. Primary outcome: 18.3.1.1 Objectively confirmed VTE. Lung eligibility wording from the registry: \"* Newly diagnosed locally advanced or metastatic primary lung cancer (histologically/ cytologically confirmed) or disease progression after complete or partial remission commencing a new course of SACT alone or as CRT\". Sites: United Kingdom. United Kingdom sites listed: 1. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT07160686","url":"https://clinicaltrials.gov/study/NCT07160686"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["lung-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["UK sites (registry): University of Birmingham (Birmingham)."],"nct":"NCT07160686","phase":"3","setting":"A Phase III, Multicentre, Double Blind, Placebo-Controlled, Randomised Clinical Trial of Apixaban THROMBOprophylaxiS TO Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment","sponsor":"University of Birmingham","participation":[{"nct":"NCT07160686","source":"https://clinicaltrials.gov/study/NCT07160686","fetchedAt":"2026-10-07T16:55:29.886Z","studySha256":"d03d728a15bf6dc0f19eca28d0fd4ed570a9dad898d8e1534e0d13dad42504fe","overallStatus":"RECRUITING","lastUpdatePosted":"2026-09-28","leadSponsor":"University of Birmingham","collaboratorCount":0,"minimumAge":"16 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":1456,"enrolmentType":"ESTIMATED","siteCount":8,"recruitingSiteCount":8,"countries":["United Kingdom"]}],"started":"2026-03-02","startedType":"estimated","enrolled":1456,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07160686/","neighbours":{"cancer":[{"id":"lung-cancer","kind":"cancer","name":"Lung cancer (all types)","route":"/cancers/lung-cancer/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}